1.
Lengline E, Beldjord K, Dombret H, Soulier J, Boissel N, Clappier E. Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion. Haematologica [Internet]. 2013Nov.1 [cited 2026Nov.3];98(11):e146-e148. Available from: https://haematologica.org/article/view/6853